AETHLON MEDICAL INC (AEMD:NASDAQ)
$2.03 0.13 (6.8421%)
Analysed AETHLON MEDICAL INC (AEMD:NASDAQ) News Sources
Sigyn Therapeutics Issues Shareholder Update Regarding Potential Merger and Asset Sale Initiatives
13-03-2026
yahoo.com
AEMD: Positive Takeaways From CEO Chat
18-03-2026
yahoo.com
OTC Markets Hosts Virtual Investor Presentation with Jim Frakes, CEO and CFO of Aethlon Medical, and M. Marin, Senior Analyst at Zacks SCR
18-03-2026
yahoo.com
Aethlon Medical, Inc. Advances to Final Cohort in Oncology Clinical Trial Following Positive DSMB Review
24-03-2026
yahoo.com
AEMD: Hitting Key Milestones as Company Advances Clinical Study
24-03-2026
yahoo.com
Aethlon Medical Monitoring Current Ebola Outbreak and Reaffirms Outbreak/Pandemic Preparedness
21-05-2026
yahoo.com
Aethlon Medical to Release Fiscal Year End Financial Results and Host Conference Call on June 10, 2026
02-06-2026
yahoo.com
Aethlon Medical Announces Fiscal Year End March 31, 2026 Financial Results and Corporate Update
10-06-2026
yahoo.com
Aethlon (AEMD) Q4 2026 Earnings Transcript
10-06-2026
fool.com
AEMD: Clinical Study Advances to Final Cohort; Preclinical Activities Expand
11-06-2026
yahoo.com
What is the current price of AETHLON MEDICAL INC (AEMD:NASDAQ)?
The current price of AETHLON MEDICAL INC (AEMD:NASDAQ) is $2.03.
AETHLON MEDICAL INC (AEMD:NASDAQ) absolute price change since previous trading day?
The absolute price change of AETHLON MEDICAL INC (AEMD:NASDAQ) since the previous trading day is $0.13.
AETHLON MEDICAL INC (AEMD:NASDAQ) percentage price change since previous trading day?
The percentage price change of AETHLON MEDICAL INC (AEMD:NASDAQ) since the previous trading day is 6.8421%.
What is the most recent average sentiment score for AETHLON MEDICAL INC (AEMD:NASDAQ)?
The most recent average sentiment score for AETHLON MEDICAL INC (AEMD:NASDAQ) is 73 out of 100.
What is the most recent average sentiment for AETHLON MEDICAL INC (AEMD:NASDAQ)?
The most recent sentiment for AETHLON MEDICAL INC (AEMD:NASDAQ) is .
SEC-8K** Filing Available For AETHLON MEDICAL INC (AEMD:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.